All Videos - PainCast

(L) Dr. Jee Youn Moon – Cancer Pain and Neuromodulation – Video Hero Slider

Watch Now

NEWEST VIDEO

Watch Now

Cancer Pain and Neuromodulation

Dr. Jee Youn Moon from Seoul discusses neuromodulation therapy for cancer pain, emphasizing the importance of correct indication and timing. Neuropathic cancer pain—caused by tumor progression, chemotherapy, or radiation—is prevalent, affecting up to 50% of patients. Evidence supports spinal cord stimulation (SCS), DRG stimulation, and peripheral nerve stimulation (PNS) for refractory neuropathic pain, especially in cancer survivors. Neuromodulation should be considered earlier in treatment, even before high-dose opioids, to improve outcomes, reduce opioid use, and enhance quality of life. Alternative modalities like scrambler therapy, electroacupuncture, and sympathetic blocks with botulinum toxin also show promise. Earlier intervention, individualized care, and multimodal strategies are essential.

(L) Dr. Stanley Golovac_Percutaneous Lumbar Decompression – Video Hero Slider (1)

Percutaneous Lumbar Decompression

This talk highlights the effectiveness and underutilization of the MILD procedure—now formally known as Percutaneous Interlaminar Lumbar Decompression—in treating lumbar spinal stenosis with neurogenic claudication. With over 110,000 cases and 88% satisfaction, it offers a non-implant, minimally invasive solution targeting the root cause: hypertrophic ligamentum flavum. Dr. Stanley Golovac explains patient identification, imaging, clinical criteria, procedural tools, and outcomes, advocating its earlier use before spacers or surgery. Emphasis is placed on diagnosing correctly, proper coding, anatomy respect during the procedure, and debulking the ligament for significant functional improvement—especially in aging populations.

Watch Now

NEWEST VIDEO

Watch Now

(L) Dr. Ale Ismael Gonzalez Cazares – Visceral Neurolytic Blocks for Cancer Pain – Video Hero Slider

NEWEST VIDEO

Visceral Neurolytic Blocks for Cancer Pain

This presentation addresses cancer-related abdominal and pelvic pain management through interventional procedures targeting sympathetic pathways. Dr. Ale reviews indications for splenic nerve neurolysis and celiac plexus block, especially for upper abdominal malignancies like pancreatic cancer. Current evidence supports these blocks (graded 2B+) for opioid-sparing analgesia, though high-quality studies are limited. Advances include CT-guided and endoscopic approaches, and adjunct use of agents like dexmedetomidine to enhance outcomes. The talk also covers superior hypogastric plexus neurolysis for refractory pelvic pain, detailing approaches, complications, and preventive measures. Emphasis is placed on early integration of these procedures and the need for better evidence to improve cancer pain care.

Watch Now

Watch Now

(L) Society Panel – Video Hero Slider

NEWEST VIDEOS

This panel discussion brings together leaders from numerous pain and neuromodulation societies worldwide to address fragmentation within the field. The conversation highlights the diversity of missions among societies like AAPM, INS, WIP, NANS, LAPS, and various state-level organizations. Each group shares its unique focus—whether it’s global education, advocacy, innovation, or specialized therapy. The panelists explore challenges in coordination, competition for resources, and diluted political voice. Despite differences, there's consensus on the need for collaboration to improve patient care and influence policy. Ideas include shared goals, joint advocacy, educational alignment, and possibly forming coalitions like radiology’s RADPAC model.

Watch Now

Watch Video

Society Panel: Discussing the importance of societies

(L) Dr. Hermant Kalia – Intrathecal Drug Delivery Novel Dosing Parameters – Video Hero Slider

NEWEST VIDEO

Intrathecal Drug Delivery Novel Dosing Parameters

This presentation focuses on precision targeted drug delivery (TDD) for cancer pain management, emphasizing recent advances in dosing strategies and intrathecal pharmacology. Dr. Hermant Kalia highlights three core pillars for improved outcomes: infusion settings, drug chemistry, and CSF flow dynamics. The updated 2024 PACC guidelines provide structured recommendations for medication selection, catheter tip placement, and patient-specific factors, stressing system-based considerations like refill logistics. Zyconotide, initially challenged by side effects, now benefits from innovative approaches such as scheduled or patient-controlled boluses, reduced concentrations, and higher infusion rates to maintain efficacy while minimizing toxicity. Precision TDD is evolving toward individualized, guideline-driven, and optimized dosing paradigms.

Watch Now

Watch Now

Slide

Dr. Jee Youn Moon from Seoul discusses neuromodulation therapy for cancer pain, emphasizing the importance of correct indication and timing. Neuropathic cancer pain—caused by tumor progression, chemotherapy, or radiation—is prevalent, affecting up to 50% of patients. Evidence supports spinal cord stimulation (SCS), DRG stimulation, and peripheral nerve stimulation (PNS) for refractory neuropathic pain, especially in cancer survivors. Neuromodulation should be considered earlier in treatment, even before high-dose opioids, to improve outcomes, reduce opioid use, and enhance quality of life. Alternative modalities like scrambler therapy, electroacupuncture, and sympathetic blocks with botulinum toxin also show promise. Earlier intervention, individualized care, and multimodal strategies are essential.

Cancer Pain and Neuromodulation

Slide

This talk highlights the effectiveness and underutilization of the MILD procedure—now formally known as Percutaneous Interlaminar Lumbar Decompression—in treating lumbar spinal stenosis with neurogenic claudication. With over 110,000 cases and 88% satisfaction, it offers a non-implant, minimally invasive solution targeting the root cause: hypertrophic ligamentum flavum. Dr. Stanley Golovac explains patient identification, imaging, clinical criteria, procedural tools, and outcomes, advocating its earlier use before spacers or surgery. Emphasis is placed on diagnosing correctly, proper coding, anatomy respect during the procedure, and debulking the ligament for significant functional improvement—especially in aging populations.

Percutaneous Lumbar Decompression

Slide

This presentation addresses cancer-related abdominal and pelvic pain managementthrough interventional procedures targeting sympathetic pathways. Dr. Ale reviews indications for splenic nerve neurolysis and celiac plexus block, especially for upper abdominal malignancies like pancreatic cancer. Current evidence supports these blocks (graded 2B+) for opioid-sparing analgesia, though high-quality studies are limited. Advances include CT-guided and endoscopic approaches, and adjunct use of agents like dexmedetomidine to enhance outcomes. The talk also covers superior hypogastric plexus neurolysis for refractory pelvic pain, detailing approaches, complications, and preventive measures. Emphasis is placed on early integration of these procedures and the need for better evidence to improve cancer pain care.

Visceral Neurolytic Blocks for Cancer Pain

Slide

Society Panel:
Discussing the importance of societies

This panel discussion brings together leaders from numerous pain and neuromodulation societies worldwide to address fragmentation within the field. The conversation highlights the diversity of missions among societies like AAPM, INS, WIP, NANS, LAPS, and various state-level organizations. Each group shares its unique focus—whether it’s global education, advocacy, innovation, or specialized therapy. The panelists explore challenges in coordination, competition for resources, and diluted political voice. Despite differences, there's consensus on the need for collaboration to improve patient care and influence policy. Ideas include shared goals, joint advocacy, educational alignment, and possibly forming coalitions like radiology’s RADPAC model.

Slide

This presentation focuses on precision targeted drug delivery (TDD) for cancer pain management, emphasizing recent advances in dosing strategies and intrathecal pharmacology. Dr. Hermant Kalia highlights three core pillars for improved outcomes: infusion settings, drug chemistry, and CSF flow dynamics. The updated 2024 PACC guidelines provide structured recommendations for medication selection, catheter tip placement, and patient-specific factors, stressing system-based considerations like refill logistics. Zyconotide, initially challenged by side effects, now benefits from innovative approaches such as scheduled or patient-controlled boluses, reduced concentrations, and higher infusion rates to maintain efficacy while minimizing toxicity. Precision TDD is evolving toward individualized, guideline-driven, and optimized dosing paradigms.

Intrathecal Drug Delivery Novel Dosing Parameters

Recent Popular

7 Results found

Videos

Pro

Harold Cordner

...+1

October 19, 2018

Published on October 19,2018 Dr. Harold Cordner demonstrates a two-needle technique for a lumbar discogram. By using an introducer, he explains, the needle entering the disc does not come in contact with the skin’s normal...

$24.95

Pro

July 27, 2017

Lumbar Medial Branch Block

Dr. Ram Pasupuleti demonstrates the proper needle placement for a lumbar medial branch block.

$24.95

July 11, 2016

Lumbar Transforaminal

Dr. Matthew Rupert demonstrates, with the use of a cadaver, ideal needle placement for transforaminal lumbar procedures using a blunt coude® needle.

Watch Now

March 25, 2015

Trans-S1 Infralaminar “Scarring Triangle” Injectates

Dr. Gabor Racz reviews the injectates and volumes for the trans-S1 infralaminar "Scarring Triangle" technique during the procedure.

Watch Now

October 2, 2014

Cadaver Workshop: Lumbar Transforaminal

Dr. John Nelson shares his thoughts on the blunt needle and performs a lumbar transforaminal using the device.

Watch Now

May 13, 2014

Interventional Pain Workshop: RX-2™ Lumbar Lysis

Dr. Gabor Racz shares the injectates and volumes for the trans-S1 infralaminar "Scarring Triangle" technique while performing the procedure.

Watch Now

April 14, 2014

Interventional Pain Workshop: Coudé® Blunt Needle

Interventional Pain Workshop: Coudé® Blunt Needle.

Watch Now